We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$378M
AUM Growth
-$14.3M
Cap. Flow
-$37.7M
Cap. Flow %
-9.99%
Top 10 Hldgs %
14.76%
Holding
326
New
67
Increased
40
Reduced
57
Closed
66

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 17.8%
3 Healthcare 17.74%
4 Materials 11.05%
5 Communication Services 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGR
151
DELISTED
Avangrid, Inc.
AGR
$1.01M 0.27%
20,000
PLUG icon
152
Plug Power
PLUG
$3B
$1.01M 0.27%
75,000
-75,000
-50% -$827K
ANIP icon
153
ANI Pharmaceuticals
ANIP
$1.77B
$1M 0.26%
35,500
BTG icon
154
B2Gold
BTG
$6.65B
$978K 0.26%
150,000
-100,000
-40% -$650K
EFOR
155
Everforth Inc
EFOR
$1.32B
$976K 0.26%
15,350
+350
+2% +$24.1K
THO icon
156
Thor Industries
THO
$4.1B
$972K 0.26%
+10,200
New +$1.06M
VVV icon
157
Valvoline
VVV
$4.5B
$971K 0.26%
51,000
-51,500
-50% -$1.06M
PAAS icon
158
Pan American Silver
PAAS
$21.4B
$964K 0.26%
30,000
-20,000
-40% -$687K
NBIX icon
159
Neurocrine Biosciences
NBIX
$16.6B
$962K 0.25%
10,000
WW
160
DELISTED
WW International
WW
$962K 0.25%
51,000
+25,000
+96% +$588K
PPL
161
PPL Corp
PPL
$26.7B
$952K 0.25%
35,000
VTRS icon
162
Viatris
VTRS
$19.3B
$919K 0.24%
62,000
QCOM icon
163
Qualcomm
QCOM
$175B
$900K 0.24%
7,650
-12,850
-63% -$1.37M
CNSL
164
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$871K 0.23%
+153,000
New +$1.06M
VIVO
165
DELISTED
Meridian Bioscience Inc
VIVO
$866K 0.23%
+51,000
New +$991K
LRCX icon
166
Lam Research
LRCX
$386B
$846K 0.22%
25,500
+20,500
+410% +$706K
JNCE
167
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$832K 0.22%
+102,000
New +$632K
SBNY
168
DELISTED
Signature Bank
SBNY
$830K 0.22%
10,000
SCPL
169
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$827K 0.22%
+51,000
New +$743K
UGI icon
170
UGI
UGI
$7.42B
$824K 0.22%
25,000
MDU icon
171
MDU Resources
MDU
$4.31B
$787K 0.21%
92,046
P
172
Everpure Inc
P
$29.4B
$785K 0.21%
+51,000
New +$834K
ED icon
173
Consolidated Edison
ED
$40B
$778K 0.21%
10,000
ALE
174
DELISTED
Allete
ALE
$776K 0.21%
15,000
FITB
175
Fifth Third Bancorp
FITB
$51.9B
$768K 0.2%
36,000

Similar funds

Hussman Strategic Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Hussman Strategic Advisors held 326 positions worth $378M, down 3.6% from $392M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Hussman Strategic Advisors withdrew a net $37.7M in Q3 2020, closing 66 positions and reducing 57 holdings. Its most notable exit was Genpact, an estimated $2.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Hussman Strategic Advisors opened a new position in United Therapeutics worth $2.58M.

  • Hussman Strategic Advisors's largest Q3 2020 buy was United Therapeutics: 25,500 shares worth $2.58M.
  • Hussman Strategic Advisors added most to Alphabet (Google) Class C in Q3 2020, an estimated $3.89M increase.
  • Hussman Strategic Advisors's biggest Q3 2020 reduction was Newmont, cutting an estimated $6.18M.
  • Hussman Strategic Advisors fully exited Genpact in Q3 2020, selling an estimated $2.8M.
  • Hussman Strategic Advisors's ten largest holdings make up 15% of its $378M portfolio in Q3 2020.
  • Hussman Strategic Advisors opened 67 new positions and closed 66 in Q3 2020.
  • Hussman Strategic Advisors's portfolio value fell 3.6% quarter-over-quarter to $378M.

Based on Hussman Strategic Advisors's 13F filing for Q3 2020, filed 2 Nov 2020.